▲ SURGE

HCW Biologics Inc.

+129.2%
HCWBNASDAQHealthcare2026-05-20
2.43
Close
1.06
Prev Close
+129.25%
Change
21.1x
Vol Ratio

Why It Surged

No related news available.

Related News

HC Wainwright & Co. Maintains Buy on SAB Biotherapeutics, Raises Price Target to $10 - SAB Biotherapeutic
Benzinga2026-05-12
Harvard Bioscience shares are trading higher after the company reported preliminary Q4 results, issued FY26 outlook and outlined its long-term strategic focus areas. - Harvard Bioscience (NASDAQ:HBIO)
Benzinga2026-02-10
HC Wainwright & Co. Reiterates Buy on Q32 Bio, Maintains $13 Price Target - Q32 Bio (NASDAQ:QTTB)
Benzinga2026-05-05
HLB생명과학, 인체조직 이식재 사업 확대
inews242026-03-24
Biohaven Warns of Broad Operational, Financial and Market Risks, Affirms Overall Risk Profile Matches Prior 10-K Disclosures
Tipranks2026-05-06

Technical Analysis

Signals
BB Upper BreakOverboughtMACD BullishAbove SMA20
Key Indicators
84.29RSI (14)
0.61SMA 20
-0.45Bollinger Lower
1.66Bollinger Upper
0.61Bollinger Mid
0.26MACD
0.08MACD Signal
0.18MACD Hist
View CompanyBack to Surge Stocks
HCW Biologics Inc. Surged +129.2% on 2026-05-20 — Analysis | Alpha Lenz